Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Anne Laure Taksin"'
Autor:
Lionel Ades, Krimo Bouabdallah, Xavier Thomas, Chantal Himberlin, Denis Caillot, Emmanuel Raffoux, Amina Cherait, Agnès Guerci, Hervé Dombret, Fatiha Chermat, Arnaud Pigneux, Sylvie Chevret, Pierre Fenaux, Anne Banos, Claude Gardin, Thorsten Braun, Jean Pierre Marolleau, Norbert Vey, Cécile Pautas, Anne Laure Taksin
Publikováno v:
Blood
Blood, American Society of Hematology, 2020, 136 (1), ⟨10.1182/blood-2020-137012⟩
Blood, American Society of Hematology, 2020, 136 (1), ⟨10.1182/blood-2020-137012⟩
Background: Results of the phase III QUAZAR trial suggest that post-remission treatment with an oral form (CC-486) of azacitidine (AZA) can prolong CR duration and overall survival(OS) in AML patients reaching at least PR with intensive chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf2294e56c43f1241c796525b2f59dce
https://hal-u-picardie.archives-ouvertes.fr/hal-03604936
https://hal-u-picardie.archives-ouvertes.fr/hal-03604936
Autor:
Charikleia Kelaidi, Aspasia Stamatoullas, Odile Beyne-Rauzy, Emmanuel Raffoux, Bruno Quesnel, Agnes Guerci, François Dreyfus, Sabine Brechignac, Christian Berthou, Thomas Prebet, Yosr Hicheri, Maya Hacini, Jacques Delaunay, Marie-Pierre Gourin, Jean-Marie Camo, Hacene Zerazhi, Anne-Laure Taksin, Laurence Legros, Bachra Choufi, Pierre Fenaux
Publikováno v:
Haematologica, Vol 95, Iss 6 (2010)
Background There is little published information on the everyday clinical management of myelodysplastic syndromes in real world practice.Design and Methods We conducted a cross-sectional study of all patients with myelodysplastic syndromes attending
Externí odkaz:
https://doaj.org/article/aa1c6bdd98dc4535865a614e074adabb
Autor:
Isabelle Cano, Hassan Farhat, Stéphanie Ghez, Marc Spentchian, Christine Terré, Florence Beckeriche, Florence Oberkampf, Pascale Cony-Makhoul, Isabel Garcia, Diane Lara, David Ghez, Stéphane de Botton, Anne Laure Taksin, Omar Benbrahim, Philippe Rousselot, Mathilde Ruggiu, Sophie Rigaudeau, Noémie de Gunzburg, Victoria Raggueneau
Publikováno v:
Leukemia & Lymphoma. 59:1659-1665
Although the tyrosine kinase inhibitor (TKI) era has brought great improvement in outcome in chronic myelogenous leukemia (CML), prognosis of accelerated phase or myeloid blast crisis patients or of de novo Philadelphia chromosome-positive acute myel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::189d2b35b9ac0ec2a1bec05caa3a3cae
https://doi.org/10.1080/10428194.2017.1397666
https://doi.org/10.1080/10428194.2017.1397666
Autor:
Victoria Raggueneau, Sylvain Pilorge, Fathia Merabet, Stéphanie Ghez, Isabelle Garcia, Clémentine Sarkozy, Anne Laure Taksin, Hassan Farhat, Sophie Rigaudeau, Claude Preudhomme, Philippe Rousselot, Christine Terré, Sylvie Castaigne, Aline Renneville, Florence Rabian
Publikováno v:
American Journal of Hematology. 89:399-403
Gemtuzumab ozogamicin (fGO), a humanized anti-CD33 monoclonal antibody linked to calicheamicin in combination with intensive chemotherapy gives high response rates in adult acute myeloid leukemia (AML) patients in relapse. However, reduced intensity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f72abd1b6085201125e75e3423d640c
https://doi.org/10.1002/ajh.23653
https://doi.org/10.1002/ajh.23653
Autor:
François Dreyfus, Agnès Guerci, Stéphane Cheze, Thomas Cluzeau, Jacques Delaunay, Pierre Fenaux, Norbert Ifrah, Anne-Laure Taksin, Yasmine Chait, Pierre Morel, Sylvain Thepot, Christian Recher, Norbert Vey, Hervé Dombret, Anne Marfaing Koka, Isabelle Plantier, Raphael Itzykson, M.P. Chaury, Valerie Seegers, Aspasia Stamatoullas, Caroline Dartigeas, Bruno Quesnel, Emmanuel Raffoux, Anne Banos, Lionel Ades, Claude Gardin, Jean Pierre Marolleau, Françoise Isnard, Cécile Pautas, Blandine Beve, Xavier Thomas
Publikováno v:
American Journal of Hematology. 89:410-416
Limited data are available on azacitidine (AZA) treatment and its prognostic factors in acute myeloid leukemia (AML). One hundred and forty-nine previously untreated AML patients considered ineligible for intensive chemotherapy received AZA in a comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91927c4641fd01f46da44a8f132bc56a
https://doi.org/10.1002/ajh.23654
https://doi.org/10.1002/ajh.23654
Autor:
Jean-Louis Georges, N. Baron, Jérôme Lambert, Philippe Rousselot, Sophie Rigaudeau, Stéphanie Ghez, Raphaele Convers-Domart, Clément Charbonnel, Anne Laure Taksin, Bernard Livarek, Juliette Lambert, Hassan Farhat
Publikováno v:
European heart journal. Cardiovascular Imaging. 18(4)
Objectives The aim of this study was to assess whether global longitudinal strain (GLS) measured early during treatment with anthracycline (at a cumulative dose of 150 mg/m2) can predict subsequent alterations in left ventricular ejection fraction (L
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a7a5bf9c5944c4dc0dbc1f053e04a1d
https://pubmed.ncbi.nlm.nih.gov/28065916
https://pubmed.ncbi.nlm.nih.gov/28065916
Autor:
Anne Banos, Celia Salanoubat, Odile Beyne-Rauzy, Aline Renneville, Claude Preudhomme, Pascale Cony-Makhoul, Stefan Wickenhauser, Christian Rose, Eric Wattel, Denis Caillot, Julie Lejeune, Francois Dreyfus, François Guilhot, G. Tertian, Agnès Guerci-Bresler, S. Nimuboma, Françoise Isnard, Laurence Sanhes, Kamel Laribi, Stéphane Cheze, Michaela Fontenay, R. Benramdane, B. de Renzis, Dominique Bordessoule, Borhane Slama, Kamal Bouabdallah, Veronique Sardnal, B. Chouffi, Berengere Gruson, Anne-Laure Taksin, Andrea Toma, Sylvie Chevret, Laurence Legros, Karim Maloum, Emmanuel Gyan, R. Petit, C. Gardin, Olivier Kosmider, Carole Soussain, Aspasia Stamatoullas, Jacques Delaunay, Pierre Fenaux
Publikováno v:
Leukemia
Leukemia, 2016, 30 (4), pp.897--905. ⟨10.1038/leu.2015.296⟩
Leukemia, 2016, 30 (4), pp.897--905. 〈10.1038/leu.2015.296〉
Leukemia, 2016, 30 (4), pp.897--905. ⟨10.1038/leu.2015.296⟩
Leukemia, 2016, 30 (4), pp.897--905. 〈10.1038/leu.2015.296〉
International audience; After failure of erythropoiesis-stimulating agents (ESAs), lenalidomide (LEN) yields red blood cell (RBC) transfusion independence (TI) in 20-30% of lower-risk non-del5q myelodysplastic syndrome (MDS). Several observations sug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7d4a3e26074be5bccd0fd0cadb50827
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01321412/document
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01321412/document
Autor:
Agnès Guerci, François Dreyfus, Geneviève Leroux, Odile Beyne-Rauzy, Sophie Park, Bruno Cassinat, Pierre Fenaux, Rosa Sapena, Anne Lazareth, Michaela Fontenay, Thorsten Braun, Virginie Eclache, Aspasia Stamatoullas, Anne-Laure Taksin, Norbert Vey, Valérie Coiteux, Dominique Bordessoule, Stéphane de Botton, Khaled Guenda, Lionel Ades, Christine Terré, Sylvie Castaigne
Publikováno v:
Leukemia Research. 35:863-867
Isolated 20q deletion is common in MDS and considered of good prognosis, but no large series have been reported. We compared characteristics of 62 MDS patients with isolated del 20q, 36 patients with del 20q and other cytogenetic abnormalities, and 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69ea9b57c2d526a45dc4eae232b76a68
https://doi.org/10.1016/j.leukres.2011.02.008
https://doi.org/10.1016/j.leukres.2011.02.008
Autor:
Sorin Visanica, Isabelle Plantier, Bruno Quesnel, Shanti Ame, Lionel Adès, Simone Boehrer, Raphael Itzykson, Françoise Isnard, Anne Marfaing-Koka, Youcef Chelghoum, C.L. Beach, Jacques Delaunay, François Dreyfus, Anne-Laure Taksin, Claude Gardin, Pascal Turlure, Sylvain Thepot, Norbert Vey, Laurence Legros, Christian Recher, Pierre Fenaux, Odile Beyne-Rauzy, Caroline Dartigeas, Aspasia Stamatoullas, Celia Salanoubat, Stéphane de Botton
Publikováno v:
Blood. 117:403-411
Prognostic factors for response and survival in higher-risk myelodysplastic syndrome patients treated with azacitidine (AZA) remain largely unknown. Two hundred eighty-two consecutive high or intermediate-2 risk myelodysplastic syndrome patients rece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5fa5398868d52a0bf2bddaa3964f51c
https://doi.org/10.1182/blood-2010-06-289280
https://doi.org/10.1182/blood-2010-06-289280
Autor:
Charikleia, Kelaidi, Aspasia, Stamatoullas, Odile, Beyne-Rauzy, Emmanuel, Raffoux, Bruno, Quesnel, Agnes, Guerci, François, Dreyfus, Sabine, Brechignac, Christian, Berthou, Thomas, Prebet, Yosr, Hicheri, Maya, Hacini, Jacques, Delaunay, Marie-Pierre, Gourin, Jean-Marie, Camo, Hacene, Zerazhi, Anne-Laure, Taksin, Laurence, Legros, Bachra, Choufi, Pierre, Fenaux, C, Fontaine
Publikováno v:
Haematologica. 95:892-899
Background There is little published information on the everyday clinical management of myelodysplastic syndromes in real world practice. Design and Methods We conducted a cross-sectional study of all patients with myelodysplastic syndromes attending
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ad88e73ae85672e47fde72fc975a7fe
https://doi.org/10.3324/haematol.2009.014357
https://doi.org/10.3324/haematol.2009.014357